Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysis
- PMID: 39129712
- PMCID: PMC11520557
- DOI: 10.1080/14796694.2024.2385296
Cancer cytogenetics in the era of artificial intelligence: shaping the future of chromosome analysis
Abstract
Artificial intelligence (AI) has rapidly advanced in the past years, particularly in medicine for improved diagnostics. In clinical cytogenetics, AI is becoming crucial for analyzing chromosomal abnormalities and improving precision. However, existing software lack learning capabilities from experienced users. AI integration extends to genomic data analysis, personalized medicine and research, but ethical concerns arise. In this article, we discuss the challenges of the full automation in cytogenetic test interpretation and focus on its importance and benefits.
Keywords: artificial intelligence; cancer; chromosome analysis; cytogenetics; karyotype; machine learning techniques.
Conflict of interest statement
The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Similar articles
-
Exploring Gender Bias in AI for Personalized Medicine: Focus Group Study With Trans Community Members.J Med Internet Res. 2025 Jul 29;27:e72325. doi: 10.2196/72325. J Med Internet Res. 2025. PMID: 40729959 Free PMC article.
-
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives.Ann Oncol. 2025 Jul;36(7):712-725. doi: 10.1016/j.annonc.2025.03.006. Epub 2025 Apr 29. Ann Oncol. 2025. PMID: 40307127
-
Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine.Epigenetics Chromatin. 2025 Jun 14;18(1):35. doi: 10.1186/s13072-025-00595-5. Epigenetics Chromatin. 2025. PMID: 40517231 Free PMC article. Review.
-
Artificial intelligence: its potential in personalized public health strategies and genetic data analysis: a narrative review.Per Med. 2025 Jun;22(3):171-179. doi: 10.1080/17410541.2025.2494501. Epub 2025 Apr 21. Per Med. 2025. PMID: 40259534 Review.
-
AML diagnostics in the 21st century: Use of AI.Semin Hematol. 2025 Jun 16:S0037-1963(25)00027-7. doi: 10.1053/j.seminhematol.2025.06.002. Online ahead of print. Semin Hematol. 2025. PMID: 40617702
Cited by
-
Incorporating automation in a cytogenetics laboratory: three practitioners' perspectives on benefits and limitations.Mol Cytogenet. 2025 Jun 12;18(1):12. doi: 10.1186/s13039-025-00716-5. Mol Cytogenet. 2025. PMID: 40506731 Free PMC article. Review.
-
The Emergence of Artificial Intelligence-Guided Karyotyping: A Review and Reflection.Genes (Basel). 2025 May 31;16(6):685. doi: 10.3390/genes16060685. Genes (Basel). 2025. PMID: 40565577 Free PMC article. Review.
-
Holistic precision wellness: Paving the way for next-generation precision medicine (ngPM) with AI, biomedical informatics, and clinical medicine.FASEB Bioadv. 2025 Mar 3;7(4):e70005. doi: 10.1096/fba.2024-00198. eCollection 2025 Apr. FASEB Bioadv. 2025. PMID: 40212810 Free PMC article.
-
Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon.Front Oncol. 2024 Oct 24;14:1480793. doi: 10.3389/fonc.2024.1480793. eCollection 2024. Front Oncol. 2024. PMID: 39512772 Free PMC article.
-
Optical genome mapping with whole genome sequencing identifies complex chromosomal structural variations in acute leukemia.Front Genet. 2025 Apr 2;16:1496847. doi: 10.3389/fgene.2025.1496847. eCollection 2025. Front Genet. 2025. PMID: 40242470 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous